CME Quote, Financials, Valuation and Earnings

Coinbase Global has a net margin of 58.22% compared to CME Group's net margin of 56.84%. CME Group's return on equity of 13.28% beat Coinbase Global's return on equity of 30.9%.

CME Group has a consensus price target of $270.35, signalling downside risk potential of -4.13%. On the other hand Coinbase Global has an analysts' consensus of $259.00 which suggests that it could grow by 25.42%. Given that Coinbase Global has higher upside potential than CME Group, analysts believe Coinbase Global is more attractive than CME Group.

CME Group has a beta of 0.447, which suggesting that the stock is 55.307% less volatile than S&P 500. In comparison Coinbase Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.72%. Coinbase Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CME Group pays 101.66% of its earnings as a dividend. Coinbase Global pays out -- of its earnings as a dividend.

CME Group quarterly revenues are $1.6B, which are smaller than Coinbase Global quarterly revenues of $2.3B. CME Group's net income of $956.2M is lower than Coinbase Global's net income of $1.3B. Notably, CME Group's price-to-earnings ratio is 28.37x while Coinbase Global's PE ratio is 21.74x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 16.16x versus 8.49x for Coinbase Global. Usually stocks with elevated PS ratios are considered overvalued.

Intercontinental Exchange has a net margin of 58.22% compared to CME Group's net margin of 24.68%. CME Group's return on equity of 13.28% beat Intercontinental Exchange's return on equity of 10.23%.

CME Group has a consensus price target of $270.35, signalling downside risk potential of -4.13%. On the other hand Intercontinental Exchange has an analysts' consensus of $192.44 which suggests that it could grow by 9.05%. Given that Intercontinental Exchange has higher upside potential than CME Group, analysts believe Intercontinental Exchange is more attractive than CME Group.

CME Group has a beta of 0.447, which suggesting that the stock is 55.307% less volatile than S&P 500. In comparison Intercontinental Exchange has a beta of 1.125, suggesting its more volatile than the S&P 500 by 12.526%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.72%. Intercontinental Exchange offers a yield of 1.04% to investors and pays a quarterly dividend of $0.48 per share. CME Group pays 101.66% of its earnings as a dividend. Intercontinental Exchange pays out 37.73% of its earnings as a dividend. Intercontinental Exchange's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Intercontinental Exchange quarterly revenues of $3.2B. CME Group's net income of $956.2M is higher than Intercontinental Exchange's net income of $797M. Notably, CME Group's price-to-earnings ratio is 28.37x while Intercontinental Exchange's PE ratio is 36.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 16.16x versus 8.34x for Intercontinental Exchange. Usually stocks with elevated PS ratios are considered overvalued.

Nasdaq has a net margin of 58.22% compared to CME Group's net margin of 18.9%. CME Group's return on equity of 13.28% beat Nasdaq's return on equity of 11.5%.

CME Group has a consensus price target of $270.35, signalling downside risk potential of -4.13%. On the other hand Nasdaq has an analysts' consensus of $83.72 which suggests that it could grow by 5.98%. Given that Nasdaq has higher upside potential than CME Group, analysts believe Nasdaq is more attractive than CME Group.

CME Group has a beta of 0.447, which suggesting that the stock is 55.307% less volatile than S&P 500. In comparison Nasdaq has a beta of 1.000, suggesting its less volatile than the S&P 500 by 0.022%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.72%. Nasdaq offers a yield of 1.22% to investors and pays a quarterly dividend of $0.24 per share. CME Group pays 101.66% of its earnings as a dividend. Nasdaq pays out 48.43% of its earnings as a dividend. Nasdaq's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than Nasdaq quarterly revenues of $2.1B. CME Group's net income of $956.2M is higher than Nasdaq's net income of $395M. Notably, CME Group's price-to-earnings ratio is 28.37x while Nasdaq's PE ratio is 35.91x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 16.16x versus 5.86x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.

S&P Global has a net margin of 58.22% compared to CME Group's net margin of 28.86%. CME Group's return on equity of 13.28% beat S&P Global's return on equity of 10.35%.

CME Group has a consensus price target of $270.35, signalling downside risk potential of -4.13%. On the other hand S&P Global has an analysts' consensus of $585.87 which suggests that it could grow by 15.42%. Given that S&P Global has higher upside potential than CME Group, analysts believe S&P Global is more attractive than CME Group.

CME Group has a beta of 0.447, which suggesting that the stock is 55.307% less volatile than S&P 500. In comparison S&P Global has a beta of 1.229, suggesting its more volatile than the S&P 500 by 22.865%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.72%. S&P Global offers a yield of 0.73% to investors and pays a quarterly dividend of $0.96 per share. CME Group pays 101.66% of its earnings as a dividend. S&P Global pays out 29.44% of its earnings as a dividend. S&P Global's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.6B, which are smaller than S&P Global quarterly revenues of $3.8B. CME Group's net income of $956.2M is lower than S&P Global's net income of $1.1B. Notably, CME Group's price-to-earnings ratio is 28.37x while S&P Global's PE ratio is 39.88x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 16.16x versus 10.87x for S&P Global. Usually stocks with elevated PS ratios are considered overvalued.